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Jian Feng, Matthew Wilkinson, Xiaochuan Liu, Immanuel Purushothaman, Deveroux Ferguson, Vincent Vialou,
Ian Maze, Ningyi Shao, Pamela Kennedy, JaWook Koo, Caroline Dias, Benjamin Laitman, Victoria Stockman,
Quincey LaPlant, Michael E Cahill, Eric J Nestler* and Li Shen*During the typesetting of the final version of the article
[1] Tables S2, S8 and S11 were duplicated and Tables S1,
S7 and S9 are missing. We apologize for the mistake that
led to the loss of some of the additional files.
In the final version of the article:
Additional file 2: Table S1 is wrongly replaced as
Table S2.
Additional file 17: Table S7 is wrongly replaced as
Table S8.
Additional file 22: Table S9 is wrongly replaced as
Table S11
Please see missing Additional files 2, 17 and 22 below.
All Additional files were correct in the provisional
version of the article. Below please find the correct full
list of Additional Files associated with this article.
Additional file 1: Figure S1. Locomotor sensitization
to repeated cocaine. Mice received daily cocaine (20 mg/kg)
or saline injections for 7 days and were evaluated for loco-
motor activity on days 1, 3, and 7. A significant (two-way
ANOVA) main effect of day (F2,36 = 4.47, P < 0.01) and
drug (F1,36 = 36.37, P < 0.0001) and an interaction between
day and drug (F2,36 = 7.38, P= 0.002) was observed (co-
caine, N = 8; saline, N = 12). Bonferroni post hoc analysis re-
veals significant increases in locomotor activity after cocaine
versus saline on days 1 and 3 (*P < 0.01) and significantly
greater activity on day 7 versus day 1 (**P < 0.01). Data are
presented as mean ± standard error of the mean.
Additional file 2: Table S1. RNA-seq quality control
metrics for acute and chronic data.
Additional file 3: Table S2. Differential RNA-seq lists.
Differential gene lists from repeated and acute cocaine RNA-
seq experiments; differential splicing lists from repeated* Correspondence: eric.nestler@mssm.edu; li.shen@mssm.edu
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Additional file 4: Figure S2. Sample splicing screen-
shots. Genome browser screenshots of alternative
splicing examples from chronic cocaine RNA-seq
experiments. The red and green tracks represent
normalized RNA-seq coverage in cocaine and saline.
The data scale is the same for both cocaine and saline.
The schemes of an alternatively spliced transcript and a
contrast transcript are shown at the bottom. The black
boxes highlight the alternative regions that show different
expression changes from the rest of the gene body.
The asterisk indicates that the isoform is predicted to
be significantly changed. FC, fold change. (A)Ttc23:
ENSMUST00000107470 (or TCONS_00070790), log2
FC = 3.7, q-value = 2E-4; ENSMUST00000126093 (or
TCONS_00070785), log2 FC = 0.7, q-value = 0.7. (B)Sp100:
ENSMUST00000147552 (or TCONS_00001011), log2
FC = 2.8, q-value = 0.01; ENSMUST00000153574 (or
TCONS_00001012), log2 FC = 1.3, q-value = 0.7. (C)Sept7:
ENSMUST00000115272 (or TCONS_00079740), log2
FC = −0.3, q-value = 0.007; ENSMUST00000060080 (or
TCONS_00079741), log2 FC = 0.3, q-value = 1.
Additional file 5: Figure S3. RNAseq nanostring val-
idation. Nanostring validation of cocaine-induced changes
in RNA expression in NAc. A separate cohort of animals
was used to validate RNA-seq results. Normalized Nano-
string read counts are shown on the y-axis. All genes dis-
play the same direction of change with significance as
seen with RNA-seq. Error bars are mean ± standard error
of the mean derived from 14 cocaine treated and 14 saline
treated samples. *P < 0.05, **P < 0.01.
Additional file 6: Table S3. GO term enrichment of
genes that have altered splicing. The altered splicing
group combines the genes that contain alternative pro-
moter usage and/or alternative splicing. DAVID is useds distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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used: biological process, cellular component, and molecu-
lar function.
Additional file 7: Extended experimental procedures.
Additional file 8: Table S4. ChIP-seq sample read sta-
tistics. #Uniq = number of uniquely aligned reads; #Rmdup
= number of reads after removing duplicates (Additional
file 7); #TotRead = total number of reads combining three
replicates; #TotNuc = total number of nucleotides.
Additional file 9: Figure S4. Global enrichment plots
and numbers of differential events. Each panel includes
five sub-figures for the enrichment, using data pooled
from the three biological replicates, of an epigenomic
mark at TSSs, gene bodies, transcriptional end sites, and
cocaine up-regulated sites and down-regulated sites.
Y-axes represent the normalized coverage (RPM) that
is averaged across all genomic regions. (A) H3K4me1.
(B) H3K4me3. (C) H3K9me2. (D) H3K9me3. (E)
H3K27me3. (F) H3K36me3. (G) RNA pol II. (H) Number
of differential events for the seven epigenomic marks.
Additional file 10: Table S5. Differential sites for the
seven epigenomic marks. diffReps is used to identify
differential sites for each of the seven epigenomic marks.
A FDR cutoff of <10 % was used to choose the sites that
are significant.
Additional file 11: Figure S5. Distribution of basal
peaks for the seven epigenomic marks. (A) H3K4me1. (B)
H3K4me3. (C) H3K9me2. (D) H3K9me3. (E) H3K27me3.
(F) H3K36me3. (G) RNA pol II.
Additional file 12: Figure S6. Heatmap showing the
enrichment of the top 30 and custom pathways among
the seven marks. The darkness of each grid represents
the statistical significance of enrichment.
Additional file 13: Table S6. Enrichment analysis of
ChIP-seq differential sites. After the differential sites are
mapped to promoter or gene body, the genes that
contain the differential sites are uploaded to IPA for en-
richment analysis. The enriched canonical pathways or
customized gene lists are extracted. Each value repre-
sents -log10(P-value) of enrichment. Co-occurrence
score (Additional file 7) is used to rank the pathways in
descending order.
Additional file 14: Figure S7. Differential sites to
exon center distance density plots (related to Figure 3).
The distance between each differential site and the clos-
est exon center was calculated. The exons were further
classified into three categories: promoter, internal, and
polyA. The density for the distance within a 10 kb win-
dow of the exon center of each type was calculated. Each
panel represents an epigenomic mark. (A) H3K4me1.
(B) H3K4me3. (C) H3K9me2. (D) H3K9me3. (E)
H3K27me3. (F) H3K36me3. (G) RNA pol II.
Additional file 15: Figure S8. Coverage plots for the
seven marks at six different types of exons (see maintext). The exons are further classified based on the
RNA-seq RPKM of the corresponding transcript: ‘High’
(≥10), ‘Medium’ (≥1 and <10), and ‘Low’ (<1). (A)
H3K4me1. (B) H3K4me3. (C) H3K9me2. (D) H3K9me3.
(E) H3K27me3. (F) H3K36me3. (G) RNA pol II.
Additional file 16: Figure S9. Construction of
cocaine-induced chromatin signatures. All chromatin
signatures are put into a signature matrix with each row
being a transcript and each column being the log fold
change of each mark at each genomic region. K-means
clustering was performed on the signature matrix to
group transcripts into signature clusters that share com-
mon chromatin modification patterns. The regions that
show significant chromatin changes were extracted to
perform motif analysis to identify potential splicing and
transcription factors.
Additional file 17: Table S7. Genome-wide association
between chromatin modification and transcriptional
change. Based on the chromatin modification at each gen-
omic region, transcripts are separated into up-regulated,
down- regulated, and non-significant (Additional file 7).
The chromatin-up and -down transcripts are correlated
with transcripts that show expression change using
Fisher’s exact test. This generates four combinations
(‘s’ = chromatin modification, ‘e’ = expression change):
s.up.e.up; s.up.e.down; s.down.e.up; s.down.e.down.
The P-values were adjusted using the BH [78] method
and a FDR cutoff of <10 % was used to select mark-
region combinations. The analysis was first done with
the enhancer regions included and then repeated with
the enhancers removed.
Additional file 18: Figure S11. Chromatin modifica-
tion heatmap for 29 signature clusters. A merged heat-
map for all 29 signature clusters with transcripts as rows
and mark-region combinations as columns. The color
key indicates log2 fold changes. Different clusters are la-
beled by different colors.
Additional file 19: Table S8. Enriched functional
terms and canonical pathways among the 29 signature
clusters. IPA was used to find the enriched biological
functions and canonical pathways among the signature
clusters. The co-occurrence score was then used to rank
the enriched terms in descending order.
Additional file 20: Motif intermediate results. This
zip file contains the textual outputs from motif analysis.
The motifs found by MEME [42] were first combined
using the Bayesian motif clustering [79] method and
then matched with known motifs. Further explanations
are provided in the enclosed README file.
Additional file 21: Figure S10. Quantitative ChIP val-
idation of cocaine-induced changes in H3K4me3 in
NAc. A separate cohort of animals was used to validate
ChIP-seq data. All genomic sites tested display the
same direction of change with significance as seen
Feng et al. Genome Biology  (2015) 16:227 Page 3 of 3with ChIP-seq. Error bars are mean ± standard error
of the mean derived from 8 to 14 replicates per con-
dition. *P < 0.05, **P < 0.01.
Additional file 22: Table S9. A2BP1 and H3K4me3
overlapping genes that are also cocaine-regulated.
Additional file 23: Table S10. A2BP1 H3K4me3
cocaine-regulated gene functional enrichment. Functional
enrichment for the genes in Additional file 22. IPA was
used to identify enriched biological functions for the genes
listed in Additional file 22 restricted to the central nervous
system.
Additional file 24: Table S11. Inter-replicate variabil-
ity of differential genes. Variability was measured by the
coefficient of variance (CV), which equals the mean di-
vided by the standard deviation. The mean and CV
values for both cocaine and saline conditions are shown.
Additional file 25: Table S12. Quality control of
RNA-seq data. RPKM values are shown for the three sa-
line samples from the acute experiment and from the
chronic experiment. MSN-enriched genes: genes
known from previous studies to be enriched in
striatal (including NAc) medium spiny neurons.
MSN-depleted genes: genes encoding related neuro-
transmitter and neuropeptide system products known
from previous studies to be expressed at low levels in
NAc. Choroid plexus-enriched genes: genes known
from previous studies to be enriched in choroid plexus,
although many of these genes are also known to be
expressed in neurons.
Additional files
Additional file 2: Table S1. RNA-seq quality control metrics for acute
and chronic data. (XLSX 13 kb)
Additional file 17: Table S7. Genome-wide association between
chromatin modification and transcriptional change. Based on the chromatin
modification at each genomic region, transcripts are separated into
up-regulated, down- regulated, and non-significant (Additional file 7).
The chromatin-up and -down transcripts are correlated with transcripts
that show expression change using Fisher’s exact test. This generates four
combinations ('s' = chromatin modification, 'e' = expression change):
s.up.e.up; s.up.e.down; s.down.e.up; s.down.e.down. The P-values were
adjusted using the BH [78] method and a FDR cutoff of <10% was used to
select mark-region combinations. The analysis was first done with the
enhancer regions included and then repeated with the enhancers removed.
(XLSX 18 kb)
Additional file 22: Table S9. A2BP1 and H3K4me3 overlapping genes
that are also cocaine-regulated. (XLSX 28 kb)
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